CNBC Analysts Highlight Biotech Stock Outperforming Broader Market

A biotech stock included on a closely watched market list is bucking broader market trends and continuing to rise, according to CNBC contributors Josh Brown and Sean Russo.

In a segment discussing their "Best Stocks" list, Brown and Sean Russo examined the performance of the unnamed biotech company, noting that its share price has continued to push higher even as other segments of the market experienced volatility, according to CNBC.

The analysts did not specify the exact name of the biotech company in the publicly available excerpt of their discussion, nor did they detail the specific factors driving the stock's performance beyond noting it was "ignoring the market noise," per the report.

CNBC's "Best Stocks" list is a recurring feature on the network in which contributors identify equities they believe are showing notable strength or weakness relative to broader market conditions.

Further details on the stock's identity, its recent price movement, and the specific catalysts behind its performance were not included in the available excerpt of the segment.